• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘦素/脂联素比值与日本人群非酒精性脂肪性肝病的肝脂肪变性相关,但与动脉僵硬度无关。

Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.

机构信息

Department of Internal Medicine, Owani Hospital, Aomori, Japan; Department of Gastroenterology, Hirosaki University Graduate School of Medicine, Aomori, Japan.

Department of Gastroenterology, Hirosaki University Graduate School of Medicine, Aomori, Japan.

出版信息

Cytokine. 2020 Feb;126:154927. doi: 10.1016/j.cyto.2019.154927. Epub 2019 Nov 27.

DOI:10.1016/j.cyto.2019.154927
PMID:31756645
Abstract

BACKGROUND AND AIMS

Cardiovascular disease (CVD) is a leading cause of mortality in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the relationship of leptin-to-adiponectin (L/A) ratio with hepatic steatosis and arterial stiffness in NAFLD.

METHODS

The subjects were 871 Japanese adults who participated in a health survey. Dietary intake, body composition, lipid profile, serum interleukin-6 (IL-6), leptin, and adiponectin were analyzed. NAFLD was defined as fatty liver on ultrasonography in the absence of other causes of steatosis. Arterial stiffness was evaluated by the brachial-ankle pulse wave velocity (baPWV).

RESULTS

The subjects with NAFLD had a greater body mass index (BMI) and body fat percentage (BFP); a higher intake of daily energy (kcal) and carbohydrates; and a higher prevalence of hypertension, diabetes, and hyperlipidemia. The subjects with NAFLD had higher serum leptin and lower serum adiponectin concentrations and a higher L/A ratio than subjects without NAFLD. The L/A ratio increased with increasing severity of steatosis. The L/A ratio showed positive correlations with BMI and BFP, and a negative correlation with age. Women had higher L/A ratio and BFP levels than men regardless of the presence or absence of NAFLD. There was a weak positive correlation between baPWV and severity of steatosis. BaPWV was strongly correlated with age, while no relation was found between baPWV and L/A ratio. IL-6 level was correlated with baPVW and age, while the correlation between Il and 6 level and L/A ratio was very weak. The L/A ratio was correlated with triglycerides and the ratio of total cholesterol to high-density lipoprotein-cholesterol.

CONCLUSION

L/A ratio and arterial stiffness were associated with the severity of steatosis, whereas there was no correlation between L/A ratio and arterial stiffness in NAFLD. These findings suggest that not only leptin and adiponectin but also other factors might be involved in the pathogenesis for atherosclerosis in NAFLD.

摘要

背景与目的

心血管疾病(CVD)是非酒精性脂肪性肝病(NAFLD)患者死亡的主要原因。本研究旨在探讨瘦素与脂联素(L/A)比值与 NAFLD 患者肝脂肪变性和动脉僵硬的关系。

方法

本研究纳入了 871 名参加健康调查的日本成年人。分析了饮食摄入、身体成分、血脂谱、血清白细胞介素-6(IL-6)、瘦素和脂联素。NAFLD 定义为超声检查无其他脂肪变性原因的脂肪肝。通过肱踝脉搏波速度(baPWV)评估动脉僵硬。

结果

NAFLD 患者的体重指数(BMI)和体脂百分比(BFP)较高;每日能量(千卡)和碳水化合物摄入量较高;高血压、糖尿病和高脂血症的患病率较高。与无 NAFLD 患者相比,NAFLD 患者的血清瘦素水平较高,而血清脂联素水平较低,L/A 比值较高。L/A 比值随着肝脂肪变性严重程度的增加而增加。L/A 比值与 BMI 和 BFP 呈正相关,与年龄呈负相关。无论是否存在 NAFLD,女性的 L/A 比值和 BFP 水平均高于男性。baPWV 与肝脂肪变性严重程度呈弱正相关。baPWV 与年龄密切相关,而与 L/A 比值无关。IL-6 水平与 baPVW 和年龄相关,而 IL-6 水平与 L/A 比值的相关性很弱。L/A 比值与三酰甘油和总胆固醇与高密度脂蛋白胆固醇的比值相关。

结论

L/A 比值和动脉僵硬与肝脂肪变性的严重程度相关,而在 NAFLD 中,L/A 比值与动脉僵硬之间无相关性。这些发现表明,在 NAFLD 中,不仅瘦素和脂联素,而且其他因素可能参与动脉粥样硬化的发病机制。

相似文献

1
Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.瘦素/脂联素比值与日本人群非酒精性脂肪性肝病的肝脂肪变性相关,但与动脉僵硬度无关。
Cytokine. 2020 Feb;126:154927. doi: 10.1016/j.cyto.2019.154927. Epub 2019 Nov 27.
2
Non-alcoholic fatty liver disease is associated with progression of arterial stiffness.非酒精性脂肪性肝病与动脉僵硬度的进展相关。
Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):218-23. doi: 10.1016/j.numecd.2014.10.002. Epub 2014 Oct 12.
3
Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.非酒精性脂肪肝与代谢风险因素及臂踝脉搏波速度之间的相关性
World J Gastroenterol. 2015 Sep 21;21(35):10192-9. doi: 10.3748/wjg.v21.i35.10192.
4
Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.非酒精性脂肪性肝病肥胖女性的低脂联素血症与膳食蔗糖和脂肪类食物摄入频率低有关。
J Hum Nutr Diet. 2014 Apr;27 Suppl 2:301-12. doi: 10.1111/jhn.12110. Epub 2013 Jun 22.
5
Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index.非酒精性脂肪性肝病作为通过心踝血管指数测量的动脉僵硬度的危险因素。
Medicine (Baltimore). 2015 Mar;94(12):e654. doi: 10.1097/MD.0000000000000654.
6
Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病肝损伤的血清脂肪因子水平
Liver Int. 2009 Oct;29(9):1431-8. doi: 10.1111/j.1478-3231.2009.02022.x. Epub 2009 Apr 24.
7
The relationship between arterial stiffness and nonalcoholic fatty liver disease.动脉僵硬度与非酒精性脂肪肝的关系。
Dig Dis Sci. 2012 Jan;57(1):196-203. doi: 10.1007/s10620-011-1819-3. Epub 2011 Jul 13.
8
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.超重患者的血清脂肪因子水平及其与非酒精性脂肪性肝病的关系。
Panminerva Med. 2014 Jun;56(2):189-93.
9
Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.在中国无症状人群中,受控衰减参数和肝脏硬度测量对于检测动脉僵硬度增加的有用性。
Medicine (Baltimore). 2020 Nov 25;99(48):e23360. doi: 10.1097/MD.0000000000023360.
10
Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population.非肥胖、非高血压且非糖尿病的中国中青年人群中非酒精性脂肪性肝病与动脉僵硬度之间的关联
J Zhejiang Univ Sci B. 2014 Oct;15(10):879-87. doi: 10.1631/jzus.B1400028.

引用本文的文献

1
Leptin Resistance and Cardiometabolic Disorders: Bridging Molecular Pathways, Genetic Variants, and Therapeutic Innovation.瘦素抵抗与心脏代谢紊乱:连接分子途径、基因变异与治疗创新
Curr Cardiol Rev. 2025;21(5):52-67. doi: 10.2174/011573403X356019250118170444.
2
Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study.青少年和青年脂肪肝的脂肪因子/肝源性激素分析:BCAMS研究的横断面和前瞻性分析
Hepatol Int. 2025 Feb;19(1):143-155. doi: 10.1007/s12072-024-10736-9. Epub 2024 Oct 14.
3
Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction.
肥胖中的脂联素抵抗:脂联素-瘦素/胰岛素相互作用。
Adv Exp Med Biol. 2024;1460:431-462. doi: 10.1007/978-3-031-63657-8_15.
4
Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.脂联素-瘦素比值可早期发现非肥胖型非酒精性脂肪性肝病,与胰岛素抵抗无关。
Ann Med. 2023 Dec;55(1):634-642. doi: 10.1080/07853890.2023.2179106.
5
Mulberry ( L.) ethanol extract attenuates lipid metabolic disturbance and adipokine imbalance in high-fat fed rats.桑(L.)乙醇提取物可减轻高脂喂养大鼠的脂质代谢紊乱和脂肪因子失衡。
Nutr Res Pract. 2022 Dec;16(6):716-728. doi: 10.4162/nrp.2022.16.6.716. Epub 2022 May 9.
6
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations.代谢相关脂肪性肝病与慢性肾脏病的相互作用:流行病学、病理生理机制与治疗策略。
World J Gastroenterol. 2022 Oct 21;28(39):5691-5706. doi: 10.3748/wjg.v28.i39.5691.
7
Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project.磐城健康促进项目中血清肌酐与胱抑素C比值与非酒精性脂肪性肝病患者骨骼肌质量和力量的关系
J Clin Biochem Nutr. 2022 May;70(3):273-282. doi: 10.3164/jcbn.21-61. Epub 2021 Nov 26.
8
Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis.代谢相关脂肪性肝病中心功能障碍的代谢生物标志物:一项横断面分析。
Nutr Diabetes. 2022 Jan 18;12(1):4. doi: 10.1038/s41387-022-00182-7.
9
A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity.女性严重肥胖患者脂肪组织中独特的非酒精性脂肪性肝病特征。
Int J Mol Sci. 2021 Sep 29;22(19):10541. doi: 10.3390/ijms221910541.
10
Adipokines and Arterial Stiffness in Obesity.脂肪因子与肥胖相关的动脉僵硬度。
Medicina (Kaunas). 2021 Jun 25;57(7):653. doi: 10.3390/medicina57070653.